2/10/12 Contest Update
A breather for biotechs from their 2012 blistering pace was inevitable. So it’s not surprising both the Contest median and NBI dropped for the week. In particular, ARRY’s pricing of its secondary share offering at a substantial discount depressed the Contest median. ARRY is held in 12 Contest portfolios.
At Friday’s close, the Contest median was up 20.65% YTD (vs. up 22.78% YTD a week ago). In comparison, the NBI was up 13.86% YTD (vs. up 15.41% YTD a week ago), while the Nasdaq Composite Index was up 11.47% YTD (vs. up 11.54% YTD a week ago).
PGO’s portfolio remains in first place with a 38.16% YTD gain. GENE’s portfolio had a good week, moving into second place with a 34.89% YTD gain and helped by a 20% position in PYMX.OB, ROBERT’s portfolio, up 31.68% YTD, jumped into third place.
At Friday's close, all 38 Contest portfolios were still in the black with 28 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a safe & fun weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
2/10/12
Rank Name Profit/Loss
1 PGO 38,156
2 GENE 34,892
3 ROBERT 31,682
4 SCARAM 30,576
5 RKRW 30,571
6 RRGE 26,874
7 MOPGCW 26,759
8 BRAD 26,059
9 ARTHUR 25,385
10 DOUGH 24,837
Week's Top 5 Gainers
Symbol 2/3 2/10 % change
DARA 1.43 1.87 30.77%
TTHI 1.54 1.95 26.62%
PCYC 19.30 23.23 20.36%
PYMX.OB 1.04 1.22 17.31%
NVIV.OB 2.09 2.36 12.92%
Week's Top 5 Losers
Symbol 2/3 2/10 % change
NGSX 1.05 0.58 -44.76%
AMRS 10.46 6.99 -33.17%
MVIR-B.ST71.00 56.75 -20.07%
ANAC 7.42 6.19 -16.58%
CORT 3.29 2.76 -16.11% |
